Time to announce another speaker for this year’s SFB960 seminar series: Dr. Arold Grünweller from the Philipps-University Marburg. On December 3rd 2015 at 2p.m. Arnold will share with us the latest research on novel inhibitors and RNA-based therapeutic strategies to target the Pim-1 kinase, an important regulator in a number of aggressive tumors. Pim-1 inhibitors also exhibit substantial antiviral activity by interfering with translation initiation and Arnold will also elude on the latest acitivities to treat Ebola-infected cells with the inhibitors.